Trust Board papers November 2012 - Barking Havering and ...

EXECUTIVE SUMMARY
TITLE:
Board Assurance Framework – 2012 Quarter 2
BOARD/GROUP/COMMITTEE:
Trust Board
1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) and
DATE:
Attached is the Board Assurance Framework for the second quarter of
2012.
The purpose of the BAF is for the risks which impact on the Trust’s strategic
& principal objectives to be assessed and current controls reviewed to
provide assurance to the Board that mitigating actions are undertaken to
reduce the impact and risk level.
Progress
Following detailed review at the October Trust Executive Committee,
elements of the BAF have been amended to reflect a more detailed risk
profile. This continues to be work in progress.
The following improvements have been made:
1. The recommendations from the recent TEC meeting have been
implemented.
2. Risk Review forms were introduced to ensure efficiency of risk
reporting.
3. Closure Forms were introduced to ensure that Clinical Directors
and General Managers gave approval for risk closure
4. Corporate Risk Register training including the use of controlling
documents is ongoing
5. Evidence of updated Action plans for each Extreme and High Risk will
streamline management of the BAF and is ongoing.
□ TEC ……….. □ STRATEGY……….…..…
□ FINANCE ……..……… □ AUDIT ………….
□ QUALITY & SAFETY
…………..………….....……….…
□ WORKFORCE
………………………………………….…
□ CHARITABLE FUNDS
………………………………...…
□ TRUST BOARD
……………………………….……….….
□ REMUNERATION
………………………………….….....
□ OTHER …………………………..……. (please
specify)
6. Continued review has resulted in the following changes to the BAF this
month: Risks Removed or Added to the BAF:
Trust Information
Status
Ref:
339 Complaints has been removed from the BAF Removed
the controls have reduced the residual risk
impact on the Trusts but it would remain on
the corporate risk register and monitored via
action plans
311 Potential severe disruption to services arising Removed
from the removal of London Deanery posts pose
major difficulties in the delivery of quality care at
KGH obstetric services. This risk was removed
following TEC review, this was approved by
the Clinical Director
323 Risk of adverse impact on profitability due to Removed
introduction of new London wide GU and FP
Tariff in April 2012, this risk would be
managed within the Women Directorate
342 Risks: Executive leadership changes would Removed
compromise the strategic agenda This risk
was closed by the CEO because of
successful recruitment of suitable strategic
directors to progress BHRUT's plans / goals.
341 End of life Strategy because the internal
control and action plan was instrumental in
reducing the risk scoring and there is
reasonable assurance that it is managed
adequately with the aid of the Life Boards
Removed
1